Oxford Drug for Bipolar Disorder May Offer Fewer Side Effects

Academic Expertise - Oxford University

9th January 2013

A drug for bipolar disorder that works like lithium, the most common and effective treatment for the condition, but without lithium's toxicity and problem side-effects has been identified by Oxford University researchers in a study in mice.

A PCT patent application covering the use of Ebselen to treat bipolar disorder has been filed.

Press release sign up
Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation